ALK Gene Rearrangement Positive
6 clinical trials · Condition
◉ Watch ALK Gene Rearrangement Positive
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC (NCT04989322) | Dr Joanne CHIU | 2021-10-05 |
| A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies (NCT04042558) | Centre Francois Baclesse | 2019-09-26 |
| Efficacy of Treatment Sequences in Patients With Non-small Cell Lung Cancer Receiving Lorlatinib (NCT03727477) | Intergroupe Francophone de Cancerologie Thoracique | 2019-02-01 |
Track ALK Gene Rearrangement Positive automatically
Every clearance here is in the API, with alerts when new ones post.